Moderna says COVID-19 vaccine is safe for teenagers

Published



Moderna’s coronavirus vaccine is safe and effective in children aged 12-17, the company announced on Tuesday morning.

The company’s study, which included 3,700 participants in the age range, found that no patient who received two doses of the vaccine got the coronavirus. Additionally, it showed an efficacy of 93% after one dose.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.